We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.16B
AUM Growth
-$602M
(-7.8%)
Cap. Flow
-$898M
Cap. Flow
% of AUM
-12.54%
Top 10 Holdings %
Top 10 Hldgs %
13.65%
Holding
1,599
New
18
Increased
215
Reduced
1,222
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin Resources
BEN
|
+$14.7M |
| 2 |
Target
TGT
|
+$11.7M |
| 3 |
W.W. Grainger
GWW
|
+$11.6M |
| 4 |
Cardinal Health
CAH
|
+$10.5M |
| 5 |
PPG Industries
PPG
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$94.4M |
| 2 |
Microsoft
MSFT
|
+$70.8M |
| 3 |
Amazon
AMZN
|
+$47.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$44.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$39.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.28% |
| 2 | Financials | 14.57% |
| 3 | Consumer Staples | 12.48% |
| 4 | Technology | 10.87% |
| 5 | Industrials | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
1401
DELISTED
Regulus Therapeutics
RGLS
| $123K | ﹤0.01% |
310
-57
| -16% | -$23.4K |
|
1402
Element Solutions
ESI
$9.34B
| $122K | ﹤0.01% |
15,051
+2,754
| +22% | +$24.6K |
|
1403
Ocular Therapeutix
OCUL
$1.89B
| $120K | ﹤0.01% |
17,423
-3,200
| -16% | -$19.5K |
|
1404
uniQure
QURE
$2.73B
| $120K | ﹤0.01% |
15,656
-2,823
| -15% | -$22.4K |
|
|
OSIR
1405
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $118K | ﹤0.01% |
23,690
-4,390
| -16% | -$22.5K |
|
|
ADVM
1406
DELISTED
Adverum Biotechnologies
ADVM
| $116K | ﹤0.01% |
2,834
-516
| -15% | -$19.6K |
|
1407
First Commonwealth Financial
FCF
$2.1B
| $111K | ﹤0.01% |
10,970
-2,448
| -18% | -$24K |
|
1408
MBIA
MBI
$297M
| $111K | ﹤0.01% |
14,295
-3,184
| -18% | -$25.1K |
|
|
KND
1409
DELISTED
Kindred Healthcare
KND
| $110K | ﹤0.01% |
10,727
-2,253
| -17% | -$25K |
|
|
CMO
1410
DELISTED
Capstead Mortgage Corp.
CMO
| $107K | ﹤0.01% |
11,335
-2,500
| -18% | -$24.9K |
|
1411
Amkor Technology
AMKR
$16.2B
| $106K | ﹤0.01% |
10,864
-2,423
| -18% | -$19.4K |
|
|
IMDZ
1412
DELISTED
Immune Design Corp.
IMDZ
| $105K | ﹤0.01% |
13,828
-2,544
| -16% | -$18.6K |
|
1413
MiMedx Group
MDXG
$621M
| $104K | ﹤0.01% |
12,101
-2,637
| -18% | -$20.9K |
|
1414
Enviri
NVRI
$636M
| $103K | ﹤0.01% |
10,369
-2,160
| -17% | -$20.6K |
|
|
TTPH
1415
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $102K | ﹤0.01% |
1,337
-248
| -16% | -$19.9K |
|
1416
Acco Brands
ACCO
$363M
| $101K | ﹤0.01% |
10,498
-2,507
| -19% | -$25.8K |
|
1417
TherapeuticsMD
TXMD
$23.7M
| $101K | ﹤0.01% |
296
-71
| -19% | -$25.9K |
|
1418
Helix Energy Solutions
HLX
$1.44B
| $98K | ﹤0.01% |
12,020
-2,537
| -17% | -$19.2K |
|
|
ECYT
1419
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $94K | ﹤0.01% |
30,401
-5,627
| -16% | -$17.5K |
|
|
ANTH
1420
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $94K | ﹤0.01% |
3,749
-666
| -15% | -$16.8K |
|
|
SDRL
1421
DELISTED
Seadrill Limited Common Stock
SDRL
| $88K | ﹤0.01% |
139
-34
| -20% | -$24.4K |
|
|
FCH
1422
DELISTED
Felcor Lodging Trust
FCH
| $87K | ﹤0.01% |
13,467
-3,213
| -19% | -$20.9K |
|
1423
First Bancorp
FBP
$4.41B
| $80K | ﹤0.01% |
15,307
-3,210
| -17% | -$14.9K |
|
1424
Lattice Semiconductor
LSCC
$18.8B
| $77K | ﹤0.01% |
11,847
-2,828
| -19% | -$17.2K |
|
|
TRST
1425
Trustco Bank Corp NY
TRST
$975M
| $77K | ﹤0.01% |
2,183
-479
| -18% | -$16.5K |
|
Similar funds
ProShare Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, ProShare Advisors held 1,599 positions worth $7.16B, down 7.8% from $7.76B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors withdrew a net $898M in Q3 2016, closing 140 positions and reducing 1,222 holdings. Its most notable exit was MEDIVATION, INC., an estimated $7.72M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in Fortive worth $1.07M.
- ProShare Advisors's largest Q3 2016 buy was Fortive: 33,277 shares worth $1.07M.
- ProShare Advisors added most to Franklin Resources in Q3 2016, an estimated $14.7M increase.
- ProShare Advisors's biggest Q3 2016 reduction was Apple, cutting an estimated $94.4M.
- ProShare Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.72M.
- ProShare Advisors's ten largest holdings make up 14% of its $7.16B portfolio in Q3 2016.
- ProShare Advisors opened 18 new positions and closed 140 in Q3 2016.
- ProShare Advisors's portfolio value fell 7.8% quarter-over-quarter to $7.16B.
Based on ProShare Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.